Qube Research & Technologies LTD Impel Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.31 - $1.75 $1 - $7
4 New
4 $0
Q2 2022

Aug 15, 2022
SELL
$5.83 - $10.12 $69,184 - $120,094
-11,867 Closed
0 $0
Q1 2022

May 09, 2022
SELL
$5.86 - $9.85 $49,663 - $83,478
-8,475 Reduced 41.66%
11,867 $76,000
Q4 2021

Feb 01, 2022
BUY
$8.33 - $12.14 $169,448 - $246,951
20,342 New
20,342 $176,000

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0
View Full List

About IMPEL PHARMACEUTICALS INC

IMPL Quotes by TradingView
  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email